Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease.
Journal: Antimicrobial agents and chemotherapy
Published: January 27, 2026
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.
Journal: Antimicrobial agents and chemotherapy
Published: February 20, 2024
Posaconazole effectiveness in rare invasive fungal infections: A systematic literature review.
Journal: International journal of antimicrobial agents
Published: December 24, 2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Journal: Clinical drug investigation
Published: June 05, 2023
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III).
Journal: Journal of the Pediatric Infectious Diseases Society
Published: February 15, 2023
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database.
Journal: Expert opinion on drug safety
Published: March 02, 2022
Voriconazole pharmacogenetics - Authors' reply.
Journal: Lancet (London, England)
Published: April 01, 2021
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Journal: Lancet (London, England)
Published: October 22, 2020
Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial.
Journal: International journal of antimicrobial agents
Published: February 20, 2020
Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection.
Journal: Advances in therapy
Published: February 20, 2020
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
Journal: PloS one
Published: February 13, 2018
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
Journal: Antimicrobial agents and chemotherapy
Published: December 04, 2017
Last Updated: 09/26/2026